Riskpilot← Back to searchSign inGet full accessVårdkonsult Värmland AB
ABActiveOrg 5592649916Kartlavsstigen 11 CMedical specialists activities · NACE 8622Est. 20201-4 employees
Revenue 2025
SEK 167K
-97% vs 2024
EBITDA margin
-368.6%
-218% vs 2024
Equity ratio
4.9%
Financial strength
Net profit 2025
SEK -316K
-177% vs 2024
| Revenue | SEK 167K | -97% |
| EBITDA | SEK -614K | -218% |
| Net profit | SEK -316K | -177% |
| Total assets | SEK 578K | -71% |
| Equity | SEK 29K | -96% |
| Employees | — | — |
Legal name
Vårdkonsult Värmland AB
Org number
5592649916
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 juli 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Vårdkonsult, då jag är legitimerad sjuksköterska ska jag hyra ut mig till andra bemanningsbolag som gör upphandlingar med kommuner i Sverige.
Address
Kartlavsstigen 11 C
Email
therese@vardkonsultvarmland.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 074 | 1 061 | 4 244 | 5 407 | 167 |
| Staff expenses | — | — | — | — | −567 |
| EBITDA | 358 | 285 | 596 | 521 | −614 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 358 | 285 | 596 | 521 | −614 |
| Net financials | — | — | — | −4 | −3 |
| Profit before tax | 278 | 215 | 446 | 518 | −316 |
| Tax | −60 | −45 | −93 | −109 | — |
| Net profit | 218 | 170 | 353 | 409 | −316 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 541 | 868 | 2 111 | 2 022 | 578 |
| Equity | 243 | 313 | 566 | 775 | 29 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 218 | 405 | 1 245 | 947 | 550 |
| Total debt | 218 | 405 | 1 245 | 947 | 550 |
EBITDA margin
-368.6%
This company
15.8%
Market median
-2433% vs market
20212025
Equity ratio
4.9%
This company
38.2%
Market median
-87% vs market
20212025
Return on equity
-1109.8%
This company
18.4%
Market median
-6132% vs market
20212025
Net profit margin
-190.0%
This company
8.1%
Market median
-2446% vs market
20212025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20212025
Debt / equity
19.28×
This company
0.62×
Market median
-3010% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JJ | Audit | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vårdkonsult Värmland AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Joakim Läckström | Audit | 0 companies |
| Kerstin Birgitta Jansson | Deputy Board Member | 0 companies |
| Claes Olof Mattias Johansson | Deputy Board Member | 0 companies |
| Therese Veronica Edqvist | Board of Directors | 0 companies |